Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Transcriptome and Cellular Evidence of Depot-Specific Function in Beef Cattle Intramuscular, Subcutaneous, and Visceral Adipose Tissues

Tegeler AP., Ford HR., Fiallo-Diez JF., Michelotti TC., Johnson BJ., Benitez OJ.

Laboratory Study, published in Biology (Basel) (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Biology (Basel) (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40723406
PMCID
PMC12292588
DOI
10.3390/biology14070848
Citations
6

Abstract (original English)

Deposition of intramuscular adipose tissue (IMAT) is the primary determinant for beef quality grade in the U.S. Accumulation of subcutaneous (SCAT) and visceral (VIAT) adipose tissue precedes that of IMAT and often leads to excessive adiposity in beef cattle. Approaches to increase marbling while limiting subcutaneous and visceral adiposity are limited. Our objective is to define the depot-specific transcriptome profile and adipocyte function in IMAT, SCAT, and VIAT in beef steers. Transcriptomics revealed the upregulation of adipogenic and lipogenic genes in SCAT and VIAT vs. IMAT. Functional transcriptome analysis demonstrated the activation of pathways for lipid metabolic processes and biosynthesis in SCAT, accompanied by increased preadipocyte proliferation, adipocyte size, and insulin responses of SCAT in vitro. While IMAT had a greater abundance of preadipocytes, they proliferated at a lower rate and differentiated into adipocytes that were smaller and less responsive to insulin compared to SCAT. The upregulation of extracellular matrix genes in IMAT suggests that fat accumulation may be limited by the muscle microenvironment. The activation of inflammatory and immune response pathways, combined with a higher abundance of immune cells, highlighted VIAT as an immune-responsive depot. Our findings reveal transcriptional and cellular profiles underlying fat deposition in SCA

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.